The HCPLive epilepsy page is a comprehensive resource for clinical news and insights on the seizure disorder. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for epileptic seizures, and more.
December 13th 2023
In recent conversations with experts in epilepsy, the impact of stigmatization remains high for patients and ongoing efforts by clinicians to address this issue in the clinical setting has been underscored, despite the global lack of awareness about new treatments and other resources.
November 28th 2019
Pregabalin May be Linked to Birth Defects, But to What Extent?
July 28th 2016Researchers caution that Pregabalin, an agent approved by the FDA to treat epilepsy, fibromyalgia, and neuropathic pain, may be associated with an increased risk of major birth defects after first trimester exposure, though results are inconclusive.
Jerome Engel from UCLA: Looking Closer at the Benefits of Epilepsy Centers
Many patients diagnosed with epilepsy need specialized treatments to help manage their symptoms. While people may associate epilepsy centers with surgical procedures they can also provide other benefits as well.
Ganaxalone Aims to Fill Unmet Need in Status Epilepticus Treatment
Status epilepticus can be one of the most debilitating and hardest to treat neurological conditions. A potential new medication aims to help this patient population through a variety of delivery methods under development.
Status Epilepticus: New Aggressive Guidelines Issued
February 23rd 2016Physicians need to be more aggressive in treating status epilepticus, prolonged seizures lasting 30 minutes, according to a new guideline from the American Epilepsy Society. Nearly a third of patients who experience this condition die.
Epilepsy: Surveying Drug Combinations
UK researchers who surveyed the literature on treating epilepsy with multiple drugs found the combination of valproate and lamotrigine appears most promising, but note that much research needs to be done to find the right therapies for individual patients,
Q&A With Steve Kanes From Sage Therapeutics: Finding New Treatments For Severe Seizure Conditions
Super refractory status epilepticus is a condition where patients can have seizures lasting anywhere from hours to months. While a developing treatment would only be used in the intensive care unit it could help patients in a very vulnerable health condition.
Q&A With Mark Halvorsen From Upsher-Smith: Nasal Spray In Development to Help Seizure Patients
Patients living with seizure clusters have very limited treatment options for their condition. Researchers are working on developing a nasal spray which could provide acute relief for these patients.
Q&A With Heath Pardoe From New York University: Measuring Brain Aging From Epilepsy Through Imaging
The longer a patient lives with epilepsy the more damage their brain can take from the countless seizures they endure. Recent research has shown that the condition can also cause a patient's brain to age beyond their years as a result of these seizures.